Page 147 - Read Online

Akinci et al. Vessel Plus 2021;5:56 https://dx.doi.org/10.20517/2574-1209.2021.20 Page 19 of 20

56. Spence JD, Del Maestro RF. Hypertension in acute ischemic strokes. Treat. Arch Neurol 1985;42:1000-2. DOI PubMed
57. Qureshi AI. The importance of acute hypertensive response in ICH. Stroke 2013;44:S67-9. DOI PubMed
58. Treatment of Acute Cerebral Hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care
Med 2010;38:637-48. DOI PubMed PMC
59. Butcher KS, Jeerakathil T, Hill M, et al; ICH ADAPT Investigators. The intracerebral hemorrhage acutely decreasing arterial pressure
trial. Stroke 2013;44:620-6. DOI PubMed
60. Carcel C, Wang X, Sato S, et al; INTERACT2 Investigators. Degree and timing of intensive blood pressure lowering on hematoma
growth in intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial-2 results. Stroke
2016;47:1651-3. DOI PubMed
61. Wang X, Arima H, Heeley E, et al; INTERACT2 Investigators. Magnitude of blood pressure reduction and clinical outcomes in acute
intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. Hypertension 2015;65:1026-32.
DOI PubMed
62. Arima H, Heeley E, Delcourt C, et al; INTERACT2 Investigators, INTERACT2 Investigators. Optimal achieved blood pressure in
acute intracerebral hemorrhage: INTERACT2. Neurology 2015;84:464-71. DOI PubMed PMC
63. Tsivgoulis G, Katsanos AH, Butcher KS, et al. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis.
Neurology 2014;83:1523-9. DOI PubMed
64. ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high
blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015;385:617-28. DOI PubMed PMC
65. Krishnan K, Scutt P, Woodhouse L, et al. Glyceryl trinitrate for acute intracerebral hemorrhage: results from the efficacy of nitric
oxide in stroke (ENOS) trial, a subgroup analysis. Stroke 2016;47:44-52. DOI PubMed
66. Gong FT, Yu LP, Gong YH, Zhang YX, Wang ZG, Yan CZ. Blood pressure control in ultra-early basal ganglia intracerebral
hemorrhage. Eur Rev Med Pharmacol Sci 2015;19:412-5. PubMed
67. Dang B, Duan X, Wang Z, He W, Chen G. A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9. Curr Drug
Targets 2017;18:1358-66. DOI PubMed
68. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale.
Neurocrit Care 2011;15:559-76. DOI PubMed PMC
69. Qureshi AI, Foster LD, Lobanova I, Huang W, Suarez JI. Intensive blood pressure lowering in patients with moderate to severe grade
acute cerebral hemorrhage: post hoc analysis of antihypertensive treatment of acute cerebral hemorrhage (ATACH)-2 trial.
Cerebrovasc Dis 2020;49:244-52. DOI PubMed
70. Shi L, Xu S, Zheng J, Xu J, Zhang J. Blood pressure management for acute intracerebral hemorrhage: a meta-analysis. Sci Rep
2017;7:14345. DOI PubMed PMC
71. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. How should we lower blood pressure after cerebral hemorrhage? Cerebrovasc Dis
2017;43:207-13. DOI PubMed
72. Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute
stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke 2013;44:3120-
8. DOI PubMed
73. Bath PM, Woodhouse LJ, Krishnan K, et al. Prehospital transdermal glyceryl trinitrate for ultra-acute intracerebral hemorrhage: data
from the RIGHT-2 trial. Stroke 2019;50:3064-71. DOI PubMed PMC
74. Gioia L, Klahr A, Kate M, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocol.
BMC Neurol 2017;17:100. DOI PubMed PMC
75. Qureshi A, Palesch Y; ATACH II Investigators. Expansion of recruitment time window in antihypertensive treatment of acute cerebral
hemorrhage (ATACH) II trial. J Vasc Interv Neurol 2012;5:6-9. PubMed PMC
76. Qureshi AI. Intracerebral hemorrhage specific intensity of care quality metrics. Neurocrit Care 2011;14:291-317. DOI PubMed
77. Griffith DN, James IM, Newbury PA, Woollard ML. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br
J Clin Pharmacol 1979;7:491-4. DOI PubMed PMC
78. Bonten TN, Plaizier CE, Snoep JJ, Stijnen T, Dekkers OM, van der Bom JG. Effect of β-blockers on platelet aggregation: a systematic
review and meta-analysis. Br J Clin Pharmacol 2014;78:940-9. DOI PubMed PMC
79. Puchstein C, Van Aken H, Anger C, Hidding J. Influence of urapidil on intracranial pressure and intracranial compliance in dogs. Br J
Anaesth 1983;55:443-8. DOI PubMed
80. Storck J, Ochs JG, Kirsten R. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-
hydroxytryptamine uptake in platelets. Int J Clin Pharmacol Ther Toxicol 1990;28:303-8. PubMed
81. Spalding A, Vaitkevicius H, Dill S, MacKenzie S, Schmaier A, Lockette W. Mechanism of epinephrine-induced platelet aggregation.
Hypertension 1998;31:603-7. DOI PubMed
82. Anfossi G, Trovati M, Mularoni E, Lanzio M, Massucco P, Emanuelli G. Influence of phentolamine on platelet aggregation,
thromboxane B2 production and release reaction. Arch Int Pharmacodyn Ther 1988;296:144-54. PubMed
83. Akpek EA, Kahraman S, Yaman A, Bulutçu E, Yavuzer S, Ozgen S. The effect of pre-induction clonidine on platelet aggregation
during minor surgery. Eur J Clin Pharmacol 1998;54:459-62. DOI PubMed
84. Willmot M, Ghadami A, Whysall B, Clarke W, Wardlaw J, Bath PM. Transdermal glyceryl trinitrate lowers blood pressure and
maintains cerebral blood flow in recent stroke. Hypertension 2006;47:1209-15. DOI PubMed
85. Butterworth RJ, Cluckie A, Jackson SH, Buxton-Thomas M, Bath PM. Pathophysiological assessment of nitric oxide (given as sodium
nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998;8:158-65. DOI PubMed